Webcast: Advancing Molecular Diagnostics in Blood Cancer Management

Accurate diagnosis and classification of haematological malignancies require advanced molecular diagnostics to uncover chromosomal and nucleotide changes beyond traditional tumor assessments. These tools play a vital role in guiding treatment, monitoring disease progression, and tailoring therapies for patients. 

This webcast explored cutting-edge advancements in molecular testing for blood cancers, including technologies like flow cytometry, immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), cytogenetics, and next-generation sequencing (NGS). The session delved into germline testing and hereditary predisposition syndromes, equipping attendees with insights to improve diagnostic precision and therapeutic strategies, particularly for myeloid malignancies.

Discover how these advancements can transform patient outcomes and drive innovation in haematological malignancy management. Read the full article or watch on demand here>>> 

This webcast was produced by Labcorp Oncology, who retains sole responsibility for the content. If you would like to sponsor a webcast or create a custom one, talk to our team today.

About Webcasts:

Our Nature Webcasts, allow you to communicate directly with your customers, drive engagement and leads with Nature’s audiences of scientists and policymakers with a webinar expertly organized by our team. 

Reaching our health sciences audiences

Take advantage of our clinical advertising and content solutions to get your message in front of the millions of healthcare professionals (HCPs) and clinical researchers reading our 1000+ clinical medicine journals. Discover our clinical medicine audiences >>